In accordance with the Company’s Policy on Insider Trading, GlaxoSmithKline Consumer Healthcare has informed about the date of commencement of closing of Trading Window shall be from June 15, 2017 and shall end 48 hours after public announcement of the Audited / Un-Audited Financial Results for the First Quarter of Financial Year 2017-18.
The above information is a part of company’s filings submitted to BSE.